Philadelphia-positive Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS trial_result · 2026-02-10
  Clinical Trial Update: A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) [Phase 1]

  A Phase 1 study of 19-28z/IL-18 in adults with acute lymphoblastic leukemia is ongoing, including Philadelphia-negative and Philadelphia-pos…

• CLINICAL_TRIALS trial_result · 2022-09-01
  Clinical Trial Update: A Study of Olverembatinib in the Treatment of Ph+ ALL [Phase 2]

  Phase 2 clinical trial update for Olverembatinib in treating Philadelphia-Positive acute lymphoblastic leukemia (Ph+ ALL).

• CLINICAL_TRIALS trial_result · 2022-01-26
  Clinical Trial Update: Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL) [Phase 2]

  Phase 2 clinical trial update on frontline dasatinib plus chemotherapy in Philadelphia chromosome–positive acute lymphoblastic leukemia (PH+…

• CLINICAL_TRIALS trial_result · 2021-09-08
  Clinical Trial Update: MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate [Phase 2]

  Phase 2 trial evaluating MRD/risk-oriented therapy with pegylated asparaginase and lineage-targeted methotrexate in untreated Philadelphia-p…

• CLINICAL_TRIALS trial_result · 2020-11-02
  Clinical Trial Update: Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia [Phase 1, Phase 2]

  Phase I/II study evaluating nilotinib combined with ruxolitinib in TKI-resistant Philadelphia chromosome-positive leukemias; trial status co…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-01-25
  Clinical Trial Update: Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) [Phase 1]

  Phase 1 study of SCH 900776 (MK-8776) with and without cytarabine in acute leukemias; the trial is terminated with posted results.